Market Overview:

The Veterinary Infectious Disease Diagnostics Market is experiencing robust expansion, driven by Growing Prevalence of Infectious Diseases in Pets and Livestock, Increasing Awareness Among Pet Owners and Technological Advancements in Diagnostic Methods. According to IMARC Group's latest research publication, "Veterinary Infectious Disease Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025–2033", The global veterinary infectious disease diagnostics market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.2% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Grab a sample PDF of this report: https://imarcgroup.com/veterinary-infectious-disease-diagnostics-market/requestsample

Our Report Includes:

• Market Dynamics
• Market Trends and Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the Veterinary Infectious Disease Diagnostics Industry:

• Growing Prevalence of Infectious Diseases in Pets and Livestock

The global landscape of animal health in 2025 is defined by a heightened risk of infectious outbreaks, with the market valued at approximately $2.64 billion. Rising temperatures and changing precipitation patterns have expanded the habitats of disease-carrying vectors like ticks and mosquitoes, leading to a surge in parasitic infections. Simultaneously, the intensification of livestock production to meet global protein demands has escalated the risk of transboundary diseases, such as the highly pathogenic avian influenza (HPAI) H5N1, which saw a commercial outbreak in Brazil in May 2025.These environmental and economic shifts are compelling a transition toward "One Health" surveillance models. By integrating human, animal, and environmental data, stakeholders aim to detect zoonotic "spillover" events before they trigger pandemics. Consequently, the demand for high-sensitivity diagnostics is no longer just a veterinary requirement but a critical component of global health security, driving an 8.9% CAGR as clinicians and government bodies seek to mitigate the massive economic burden of livestock loss and cross-species transmission.

• Increasing Awareness Among Pet Owners

Rising awareness among pet owners about the importance of early disease detection is a crucial factor driving the market growth. With pets being considered integral family members, owners are increasingly prioritizing their health and well-being. This heightened awareness has led to a growing demand for regular health check-ups, preventive measures, and early diagnostic tests. The availability of advanced diagnostic tools and technologies has made it easier for pet owners to access high-quality veterinary care, further driving demand for infectious disease diagnostics and creating a more proactive approach to animal healthcare.

• Technological Advancements in Diagnostic Methods

Veterinary infectious disease diagnostics are witnessing considerable demand due to rapid technological advancements. Improvements in diagnostics have greatly improved the efficiency and accuracy of the results, which is further fueling the market growth. The introduction of molecular diagnostic technologies, such as polymerase chain reaction (PCR), designed to improve detection and identification in animal infectious diseases is facilitating the market growth. The incorporation of digital health tools, such as automated analyzers and telemedicine platforms, have simplified the diagnostics process, enhancing precision and accessibility for veterinary professionals worldwide.

Key Trends in the Veterinary Infectious Disease Diagnostics Market

• Immunodiagnostics Technology Leadership

The immunodiagnostics segment remains the dominant force in 2025, capturing nearly 49% of the market share. This leadership is sustained by the widespread adoption of Enzyme-Linked Immunosorbent Assays (ELISA) and lateral flow assays, which offer a perfect balance of cost-efficiency and clinical reliability. Recent innovations have introduced multiplexed cartridges that can simultaneously detect multiple pathogens—such as parvovirus, coronavirus, and Giardia—in a single ten-minute run. These "all-in-one" panels improve the economic math for clinics facing labor shortages by reducing hands-on time. Furthermore, the integration of proprietary chemistry in branded consumables ensures a steady revenue stream for manufacturers, as veterinarians increasingly rely on these standardized kits for routine wellness screenings and rapid bedside triage.

• Companion Animals Dominating Animal Type Segments

The companion animal segment leads the market with an estimated 55% share in 2025, fueled by the "pet humanization" trend where owners view diagnostics as essential wellness investments rather than discretionary costs. In the U.S. alone, nearly 94 million households now own at least one pet, significantly expanding the patient base for infectious disease screening. This demographic shift is particularly strong among Millennial and Gen Z owners, who show a higher willingness to pay for premium, AI-assisted diagnostics that provide immediate, actionable insights. The rise of pet insurance has also played a pivotal role, as policy coverage often incentivizes regular diagnostic testing. This proactive healthcare culture ensures that even minor symptoms are met with comprehensive testing, solidifying the companion segment's role as the primary revenue generator for the diagnostic industry.

• Reference Laboratories Leading End User Applications

Reference laboratories continue to lead end-user applications, accounting for over 45% of global revenue due to their ability to handle increasingly complex diagnostic requirements. While point-of-care (POC) testing is growing for rapid triage, reference labs remain the gold standard for high-throughput molecular testing and definitive confirmation of emerging pathogens. In 2025, these facilities are leveraging AI-powered image analysis and Next-Generation Sequencing (NGS) to differentiate between similar viral strains and monitor antimicrobial resistance (AMR) patterns. The "corporatization" of veterinary practices has further consolidated sample volume toward large-scale lab networks like IDEXX and Antech. These labs offer centralized data hubs that provide veterinarians with sophisticated epidemiological insights, making them indispensable for the comprehensive management of both chronic and acute infectious diseases.

Our comprehensive veterinary infectious disease diagnostics market outlook reflects both short-term tactical and long-term strategic planning. This analysis is essential for stakeholders aiming to navigate the complexities of the veterinary infectious disease diagnostics market and capitalize on emerging opportunities.

Leading Companies Operating in the Global Veterinary Infectious Disease Diagnostics Industry:

• Abbott Laboratories
• Biomérieux SA
• Creative Diagnostics
• HESKA Corporation
• Innovative Diagnostics
• IDEXX Laboratories Inc.
• Neogen Corporation
• Qiagen N.V.
• Randox Laboratories Ltd
• Thermo Fisher Scientific Inc
• Virbac

Veterinary Infectious Disease Diagnostics Market Report Segmentation:

Breakup by Technology:

• Immunodiagnostics
• Molecular Diagnostics
• Others

Immunodiagnostics accounts for the majority of the market share due to increasing demand for accurate disease detection with tests specifically detecting antibodies or antigens related to infectious diseases.

Breakup by Animal Type:

• Companion Animals
• Food Producing Animals

Companion animals holds the largest share of the industry driven by focus on pet health and wellness, advancements in diagnostic technology, and increasing prioritization of early disease detection by pet owners.

Breakup by Infection Type:

• Bacterial Infections
• Viral Infections
• Parasitic Infections
• Others

Bacterial infections represent the leading market segment driven by burgeoning prevalence of bacterial diseases among animals and rising incidence of bacterial infections such as leptospirosis, tuberculosis, and salmonella in both pets and livestock.

Breakup by End User:

• Reference Laboratories
• Veterinary Laboratories and Clinics
• Point of Care/In House Testing
• Research Institutes and Universities

Reference laboratories dominates the market due to escalating complexity of diagnostic testing requirements and increasing reliance on their advanced capabilities and specialized expertise for accurate and comprehensive diagnostic tests.

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America leads the market, accounting for the largest veterinary infectious disease diagnostics market share driven by growing prevalence of infectious diseases among pets and livestock and burgeoning awareness among pet owners about importance of early detection and prevention.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1–201971–6302